Tian'an is a China-based distributor of graphene-based health therapy products. Operating primarily through its subsidiary Shanghai Qige, the company sells wearable and at-home therapeutic devices that utilize graphene heating films to emit far-infrared radiation. Tian'an markets these products to promote blood circulation and relieve joint and muscle pain for individuals with chronic conditions. Its catalog includes energy rooms, heating blankets, knee pads, heated pillows, and moxibustion instruments. Tian'an does not manufacture its inventory; the company acts as a marketing and distribution entity that sources finished products from third-party suppliers such as Xiwang New Materials Technology and Shenzhen Innovation Technology. Sales are generated through customer referrals and an outbound marketing team. The company uses a dual settlement model with cash-on-delivery for smaller customers and 60-day credit terms for larger accounts. Tian'an pivoted to this business in Q3 2022, moving away from its former focus on power control systems. Growth initiatives include expanding its sales network within China, pursuing horizontal or vertical M&A, and launching healthcare services through its Henan Qige subsidiary. Additionally, Tian'an intends to develop a digital after-sales support platform and adjust its product offerings based on consumer feedback.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →